Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

2017 ◽  
Vol 5 (5) ◽  
pp. 390-400 ◽  
Author(s):  
Geoffrey L Chupp ◽  
Eric S Bradford ◽  
Frank C Albers ◽  
Daniel J Bratton ◽  
Jie Wang-Jairaj ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document